UK Public Sector Contracts & Tenders

Urgent award notice under the Provider Selection Regime 2023 for the provision of NHS Talking Therapies and Psychological Therapies for Severe Mental Health Problems Services for NHS Mid and South Essex Integrated Care Board (herein referred to as 'the Authority'). The awarded contract is for the provision of NHS Talking Therapies and Psychological Therapies for Severe Mental Health Problems Services, that are aimed at improving mental health outcomes by providing evidence-based therapeutic interventions. The services will be delivered through a combination of face-to-face, online, and telephone consultations. It will cater to individuals experiencing mild to moderate mental health issues, such as anxiety and depression, ensuring timely access to professional support.

Urgent award notice under the Provider Selection Regime 2023 for the provision of NHS Talking Therapies and Psychological Therapies for Severe Mental Health Problems Services for NHS Mid and South Essex Integrated Care Board (herein referred to as 'the Authority'). The awarded contract is for the provision of NHS Talking Therapies and Psychological Therapies for Severe Mental Health Problems Services, that are aimed at improving mental health outcomes by providing evidence-based therapeutic interventions. The services will be delivered through a combination of face-to-face, online, and telephone consultations. It will cater to individuals experiencing mild to moderate mental health issues, such as anxiety and depression, ensuring timely access to professional support.

Urgent award notice under the Provider Selection Regime 2023 for the provision of NHS Talking Therapies and Psychological Therapies for Severe Mental Health Problems Services for NHS Mid and South Essex Integrated Care Board (herein referred to as 'the Authority'). The awarded contract is for the provision of NHS Talking Therapies and Psychological Therapies for Severe Mental Health Problems Services, that are aimed at improving mental health outcomes by providing evidence-based therapeutic interventions. The services will be delivered through a combination of face-to-face, online, and telephone consultations. It will cater to individuals experiencing mild to moderate mental health issues, such as anxiety and depression, ensuring timely access to professional support.

This Intention to Award Notice is issued in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 under the competitive process. The Procurement relates to the Invitation to Tender (competitive process) for the provision of Lot 1: Healthy Minds Services and Lot 2: Depression and Wellbeing Calls Service (mental health services) for NHS Mid and South Essex Integrated Care Board (herein referred to as the 'Authority'). The Authority has undertaken a full evaluation and assessment of the compliant bid submissions received as part of this competitive process, which were evaluated in line with the procurement documentation published within the Competitive Process Overview (CPO). The contract award criteria are specified in the procurement documentation and CPO. As a result of this, the Authority intends to award the proposed Contract for the Service to the Provider that achieved the highest technical and commercial scores across the key criteria used. The purpose of this competitive process was for the Authority to secure a suitably qualified provider to deliver this Lot 1: Healthy Minds Service and Lot 2: Depression and Wellbeing Calls Service across Mid and South Essex. The contract term for both LOT 1 and LOT 2 is from 01st October 2025 - 30th September 2028, with the option to extend for a further 24 months. The maximum 3-year contract value for LOT 1 is £3,890,885.00 Pound Sterling, which acts as an affordability cap for the commercial offer template for this procurement. The total aggregate contract value for LOT 1 over the 5-year contract term (inclusive of optional extensions) is £6,466,732.00 Pound Sterling. The maximum 3-year contract value for LOT 2 is £285,875.00 Pound, which acts as an affordability cap for the commercial offer template for this procurement. The total aggregate contract value for LOT 2 over the 5-year contract term (inclusive of optional extensions) is £475,130.00 Pound Sterling. The selected provider was selected due to achieving the highest scores across the key criteria used. The provider has been assessed and passed against the relevant key criteria. As outlined in the procurement documentation, the key criteria contained Technical Questions. The raw weighting and applied weightings have been assigned per Key Criterion in accordance with its relative importance in line the assessment of this tender process as determined by NHS MSE ICB. The Tender was assessed on Quality (90% weighting) and Price (10% weighting). Key Criteria was: Quality and Innovation 18.00% (out of 90%) Value 13.50% (out of 90%) Integration, Collaboration and Service Sustainability 31.50.00% (out of 90%) Improving Access, Reducing Health Inequalities and Facilitating Choice 18.00% (out of 90%) Social Value 9.00% (out of 90%) This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

This notice is a confirmation to award a contract under the Most Suitable Provider process further to the observation of a standstill period. NHS Mid and South Essex Integrated Care Board ICB (M&SEICB), the contracting authority, has a responsibility to commission primary medical services on behalf of the local population. This duty is overseen by the Primary Care Commissioning Committee. Due to significant housing growth, a new primary medical care health center is due to open at Beaulieu Park, located in Chelmsford Essex in Autumn 2024 to meet the health needs associated with the housing growth. The ICB intends to operate this new site as an additional site of an existing local primary care provider - local practices (non- special allocation service) whose boundary covers the practices site; and/or local practices (non- special allocation service) with a clinic site within 7km of the Beaulieu Park site of Primary Medical Services under an GMS or APMS contract. The Beaulieu Park services are to be provided under the providers’ existing contract, with the Beaulieu Park site added as an additional service location. Services for the Beaulieu Park primary care services will be provided by way of a variation to the successful providers’ existing APMS or GMS contract. Any new patients registered, associated with the Beaulieu Park site, will be funded at GMS rates – if a provider is currently on an APMS contract new patients registered associated with the Beaulieu Park site will be funded at GMS rates. Providers will need to accept a patient list size of zero from day one of the contract with the Beaulieu Park new housing residents becoming registered and through patient choice any patients choosing to register from their current practice to the new Beaulieu Park provider.

An urgent award is required for continuity of service and safety of patients undergoing rehabilitation. There are limited Level 2b neurological rehabilitation providers within the East of England, meaning that the beds at these units are highly sought after, with competition from neighbouring ICBs (who currently are charged a higher spot purchase rate than the above MSE ICB spot purchase rate). The urgent award is required in order for MSE ICB to continue to receive the commercially beneficial rates for placements • The award must be made urgently in order for the residents of MSEICB to access specialist and quality neurological rehabilitation services from providers who are known to deliver good clinical outcomes in the population, and have demonstrated excellent ability to engage in timely discharge processes, supporting the 8-12 week pathway and facilitating flow through acute beds into specialist rehabilitation. • Delaying the award to conduct a full application of the PSR would be likely to pose a risk to both the patient safety of those requiring Level 2 neuro rehabilitation by delaying their access to the most appropriate care at the most appropriate time in the most appropriate setting. It would also impact patient safety of a wider population by preventing flow from acute beds, impacting on bed occupancy. Procurement is being developed to include the services from April '25 The contract is for one year from 1st April 2024 – 31st March 2025

This is a contract award notice to communicate that NHS Mid and South Essex Integrated Care Board (herein "the Authority") has awarded this Round 1 of the Pseudo Dynamic Purchasing System (PDPS) framework provision NHS Mid and South Essex Integrated Commissioning Board (NHS MSE ICB) is seeking to establish a Pseudo Dynamic Purchasing System (PDPS) framework provision for small and medium enterprises (SME)s, Voluntary Sector Charity Organisations (VSCOs), and organisations who could deliver purpose led services within the Mid and South Essex ICB localities. As advertised within the previous Find a Tender Opportunity Advert (notice number 2023/S 000-037030), the Services to which this procurement relates above threshold of the Light Touch Regime of the Public Contract Regulations (PCR 2015) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). This procurement commenced before the 01st January 2024 and therefore the Health and Care Act 2022 and the new regime. For absolute clarity, the Provider Selection Regime (PSR) does not apply to this specific contract award for this "Round 1" of the PDPS Framework. All new opportunities or "Rounds" will be appropriately advertised on the Find a Tender Service platform and will be in accordance with the PSR.

The service provided under this notice will be for Elective Services under patient choice provision. This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The actual contract value will vary dependent on the activity delivered. Therefore, this notice outlines a total contract value of £1.00. The indicative aggregate contract value for the most recent contractual year was £1,607,183.00

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award contract to deliver Specialist ASD Assessments for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £775,000.00 This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037656) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver a number of Tier 2 Services (Podiatric Surgery, MSK, Minor Operations, Endoscopy, ENT and Dermatology) to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037835) on the 22nd December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months, from 01st April 2024 - 31st March 2025 to align with other Tier 2 Services across the ICB . The aggregate contract value is forecasted at £6,746,744.00

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver the provision of Improving Access to Phycological Therapies (IAPT) for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037582) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £2,884,013.00

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037589) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £3,019,454.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037590) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 12 months from 01st April 2024 - 31st March 2025, with an aggregate contract value is forecasted at £1,063,075 to incumbent provider Thurrock Health Hubs. The Authority is commencing a procurement-process for it's own MSK Services for the whole of the ICB and will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037588) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority has therefore taken the decision to award this Tier 2 Endoscopy Service (which was previously for Thurrock CCG, CPR & Southend CCGs) to incumbent provider Eastwood. The Authority will enter into a contract for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £2,381,000. This contract is to ensure continuity of care, safe and effective access to care and dermatology services for the patients of Mid and South Essex during this transitional, interim period. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037587) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority has therefore taken the decision to award this Tier 2 Endoscopy Service (which was previously for Basildon and Brentwood CCG and Thurrock CCG) to incumbent provider Chartwell Hospital. The provider is considered most technically capable of providing the most economically advantageous solution to the Authority under the current environment whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to support a combination of services, all of which are part funded under a single clinical contract, to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. It is noted that the nature of the contract is non-guarantee of activity and technically valued at £0.00. The Authority has utilised actual activity figured from 2022/23 in order to forecast the aggregate contract value of The aggregate contract value of £1,323,000. This contract is being awarded to ensure continuity of care, safe and effective access to care and endoscopy services for the patients of Mid and South Essex during this transitional, interim period. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Ultrasound Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037584) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,441,870.00

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Autism Spectrum Disorder (ASD) Assessments to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032173) on the 15th December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £716,895.

The ICB Commissioners in NHS Mid and South Essex wish to provide their patients with a choice of providers who can deliver high quality Children and Young People (CYP) ADHD/ASD Services and care in accordance with the terms of this agreement and in particular all relevant Guidance. The service provided under this notice will be for Children and Young People (CYP) ADHD/ASD Services under patient choice provision. The contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. These contracts have been awarded with no guarantee of activity. The actual contract value will vary dependent on the activity delivered. Therefore, this notice outlines a total contract value of £0.00. )